Microbot Medical (MBOT) Operating Expenses (2010 - 2026)

Microbot Medical has reported Operating Expenses for 17 years, with the latest figure at $557000.0 in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 7.32% year-over-year to $557000.0; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (up 4.62% YoY), and the FY2025 full-year result was $2.8 million, up 7.79% from the prior year.
• Operating Expenses for Q1 2026 stood at $557000.0, down from $4.9 million in the prior quarter.
• The five-year high for Operating Expenses was $4.9 million in Q4 2025, with the low at -$1.0 million in Q2 2025.
• Historically, Operating Expenses has averaged $1.8 million across 5 years, with a median of $2.3 million in 2023.
• Annual changes were most pronounced in 2024 — Operating Expenses sank 127.45% — and 2025, when it jumped 188.57%.
• Microbot Medical's Operating Expenses stood at $3.1 million in 2022, then plunged by 32.59% to $2.1 million in 2023, then soared by 111.07% to $4.4 million in 2024, then advanced by 12.9% to $4.9 million in 2025, then plunged by 88.7% to $557000.0 in 2026.
• The last three Operating Expenses figures came in at $557000.0 (Q1 2026), $4.9 million (Q4 2025), and -$635000.0 (Q3 2025), per Business Quant data.